| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | DE19955130A1 Hydroxamsäurederivate Hydroxamic |
| 05/23/2001 | CN1066174C Water isoluble azoie color based on amino quinazoline dione |
| 05/23/2001 | CN1066142C 喹唑啉衍生物 Quinazoline derivatives |
| 05/23/2001 | CN1066141C 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation |
| 05/23/2001 | CN1066140C Acylated aminophenylsulphonylureas, process for their preparation and their use as herbicides and plant-growth regulators |
| 05/23/2001 | CN1066139C Use of conjugated compounds containing pyrimidine groups as electroluminescence materials |
| 05/23/2001 | CN1066133C Substituted (hetero) aryl compounds, process for preparation, agents containing them, and their use |
| 05/22/2001 | US6235904 Valuable intermediates for organic syntheses, especially for preparing crop protection agents. |
| 05/22/2001 | US6235903 Method for preparing sulfanyl-type endothelin receptor antagonists |
| 05/22/2001 | US6235790 Hydroxamic-acid derivatives, method of preparing them and their use as fungicides |
| 05/22/2001 | US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 05/22/2001 | US6235746 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 05/22/2001 | US6235744 Synergistic mixture |
| 05/22/2001 | US6235743 Fungicides; bactericides |
| 05/22/2001 | US6235738 Brain disorders; antiischemic agents |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034576A2 Use of pyrimidinone derivatives for controlling undesired microorganisms |
| 05/17/2001 | WO2001034575A1 Substituted phenyluracils and their use as herbicides |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001034136A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 05/17/2001 | DE19954816A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
| 05/17/2001 | DE19954312A1 Substituierte Phenyluracile Substituted Phenyluracils |
| 05/17/2001 | CA2390797A1 Methods for the treatment and prevention of neurodegenerative conditions |
| 05/17/2001 | CA2390645A1 Substituted phenyluracils and their use as herbicides |
| 05/17/2001 | CA2390524A1 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/16/2001 | EP1099692A1 N,n-substituted cyclic amine derivatives |
| 05/16/2001 | EP1098887A1 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same |
| 05/16/2001 | EP0843666B1 4-substituted 5-polycyclylpyrimidine herbicides |
| 05/16/2001 | CN1295565A Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 05/16/2001 | CN1295564A HIV inhibiting pyrimidine derivatives |
| 05/16/2001 | CN1295548A Novel tricyclic compound |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295477A Preventives/remedies for urinary disorder |
| 05/16/2001 | CN1295067A Acylated amino-benzenesulfonyl urea, its prep. and use as herbicide and plant-growth regulator |
| 05/16/2001 | CN1294852A Use of pyridone derivatives in control of undesired microbe |
| 05/16/2001 | CN1065862C N-(2-amino-4, 6-pyrimidine bichloride-5-) formamide and preparation of same |
| 05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/15/2001 | US6232375 4-aminopyrimidinones and oxazolidino-4-aminopyrimidinones, process for their preparation and their use for stabilizing halogen-containing polymers |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232318 Compounds such as 1-benzyl-3-(3-(4-(4-fluorophenyl)piperidin -1-yl)propyl)-5-methyl-1h-pyrimidine-2,4-dione; provides relief to males suffering from benign prostatic hyperplasia |
| 05/15/2001 | US6232316 Such as parkinson's disease, tourette's syndrome, schizophrenia, and senile dementia of alzheimers disease |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly. |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/15/2001 | CA2039039C Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient |
| 05/10/2001 | WO2001032633A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | WO2001032632A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 05/10/2001 | WO2001032626A1 Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 05/10/2001 | WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032214A1 Inhibitors against vascular lipid deposition containing chymase-inhibiting substances |
| 05/10/2001 | WO2001007418A3 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 05/10/2001 | WO2000073276A3 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists |
| 05/10/2001 | DE19953647A1 Wasserlösliche Monoazoverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Farbstoffe Water-soluble monoazo compounds, to processes for their preparation and their use as dyes |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389377A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | CA2358314A1 Blood vessel lipid deposition-preventive agent comprising chymase-inhibitor |
| 05/09/2001 | EP1097970A2 Water-soluble monoazo compounds, process for their preparation and their use as dyestuffs |
| 05/09/2001 | EP1097932A1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same |
| 05/09/2001 | EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097144A1 Method for producing 4,6-disubstituted 2-isocyanatopyrimidines and to their use as intermediate products for active ingredient syntheses |
| 05/09/2001 | EP1097143A1 Method for preparing 5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4(1h,3h)-dione |
| 05/09/2001 | CN1294582A Novel nucleic acid trangsfer agents, compsns, contg. same and uses |
| 05/09/2001 | CN1294568A Fluorinating agent, process for producing same, and use thereof |
| 05/09/2001 | CN1293896A Antifungal active compound compsns. |
| 05/09/2001 | CN1293893A Antifungal active compound compsns. |
| 05/09/2001 | CN1065559C Photo-cross-linkable optically active compounds |
| 05/09/2001 | CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228861 Benign prostatic hyperplasia; anticholesterol agents; impotency; intraocular pressure; antiarrhythmia agents |
| 05/08/2001 | US6228809 Substituted aminophenyluracils as herbicides and insecticides |
| 05/08/2001 | US6228808 Carbamoylphenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2032141C Pharmaceutically active agents that impede amyloid formation in vivo |
| 05/08/2001 | CA2027530C W-phenoxy-heterocyclic compounds |
| 05/03/2001 | WO2001030791A2 Method for the preparation of 2',3'-didehydro-2',3'-dideoxycytidine derivatives |
| 05/03/2001 | WO2001030768A1 Methods and compositions utilizing quinazolinones |
| 05/03/2001 | WO2001030767A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | WO2001030328A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 05/03/2001 | DE19951702A1 Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten Use of 2-amino-3,4-dihydro-quinazolines for the preparation of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
| 05/03/2001 | DE19951671A1 2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionssäure-Natriumsalz und seine Verwendung als Endothelinantagonist and its use as an endothelin antagonist |
| 05/03/2001 | CA2389012A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | CA2388965A1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |